CRCharles R. Rosenfeld

Charles R. Rosenfeld

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Charles R. Rosenfeld has a total of 75 co-authors. Here are the top co-authors by number of shared publications:

  • L. Steven Brown

    Parkland Health and Hospital Systems, Dallas, USA

    13 shared publications
  • Luc Pierre Brion

    Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, USA

    13 shared publications
  • Roy Heyne

    Department of Pediatrics, UT Southwestern Medical Center, Division of Neonatal-Perinatal Medicine, Dallas, USA

    11 shared publications
  • Patti J. Burchfield

    Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas

    8 shared publications
  • Maria Caraig

    Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, USA

    7 shared publications
  • Xiao-Tie Liu

    Department of Pediatrics, Division of Neonatal-Perinatal Medicine, UT Southwestern Medical Center, Dallas, TX, USA

    7 shared publications

Latest Publications

  • Relationship between serum lipids/adipokines and obesity/hypertension in very-preterm infants during early childhood and preadolescence

    by Charles R. Rosenfeld, L. Steven Brown, Valerie Blanco, Roy Heyne

    Background Childhood overweight/obesity is associated with elevated systolic blood pressure (SBP) and increased cardiovascular risk as adults. Preterm birth (PTB) is a risk factor for childhood overweight/obesity. Few longitudinal studies of childhood obesity following PTB include longitudinal serum adipokine/lipid measurements. Methods We reenrolled 62/120 children 10–13 years old born ≤32 weeks gestational age (GA) and originally seen at 1–3 years. We measured anthropometric indices, SBP and serum lipids/adipokines and matched them with Term-Born controls (n = 62:124; 2015–2016 NHANES database). Results PTB are 86% Hispanic, birthweight 1073 ± 251 (SD)gm and GA 28 ± 2 weeks. Follow-up was at 11 ± 1 year. BMIz ≥85th centile occurred in 45% PTB and 48% Term-Controls; however, SBP ≥90th centile was 48% vs. 12% (P < 0.01), respectively. Although weight gain velocity (WtGV) birth to 10–13 years and anthropometric indices were similar, WtGV predicted overweight/obesity and elevated/hypertensive SBP (P ≤ 0.03) in PTB. PTB serum triglyceride and low-density lipoprotein concentrations exceeded Term (P ≤ 0.02); moreover, 44% PTB had triglyceride >130 mg/dL vs. 5% Term. Serum leptin and leptin:adiponectin ratio increased ≥4-fold in PTB at 10–13 years, females » males, and correlated with overweight/obesity and elevated/hypertensive SBP. Conclusions Early adolescent White Hispanic children born ≤32 weeks GA exhibit elevated serum adipokines, dyslipidemia and central obesity plus hypertension, which are predicted by WtGV, a potential tool for identifying at-risk childhood populations. Impact statement Key message: Birth ≤32 weeks gestational age (GA) in a predominantly Hispanic population is associated with increased risk for overweight/obesity and hypertension in early adolescence that correlate with excessive weight gain and elevated serum triglyceride/leptin concentrations. Addition to the literature: Prospective assessment of anthropometric measurements and serum adipokines/lipids during early childhood and early adolescence in Hispanics born ≤32 weeks GA. What is the impact: Demonstrates increased risk in Hispanic children born ≤32 weeks GA for obesity and hypertension during childhood and evidence that weight gain velocity from birth to early adolescence may identify those at-risk for adult onset of cardiovascular and metabolic disease.


  • Follow-up of a randomized trial optimizing neonatal nutrition in preterm very low birthweight infants: growth, serum adipokines, renal function and blood pressure

    by Jordan D. Reis, Roy Heyne, Charles R. Rosenfeld, Maria Caraig, L. Steven Brown, P. J. Burchfield, Cheryl S. Lair, Elen Petrosyan, Theresa Jabob, David B. Nelson, et al.

    Objective The primary objectives were to compare body mass index (BMI) Z-score (Z), systolic blood pressure (SBP), serum leptin:adiponectin (L:A) ratio and estimated glomerular filtration rate (eGFR) at ~3 years adjusted age between two arms of a randomized controlled trial (RCT) comparing two modes of human milk fortification for very low-birthweight infants in the neonatal intensive care unit. Study design Follow-up of RCT at 33–48 months. Results Follow-up data are available in 82/120 infants. Infants in the experimental arm have anthropometric data consistent with central obesity and higher serum L:A ratio (sensitivity analysis adjusting for sex and using all available data), but have similar eGFR and SBP at follow-up compared with controls. Serum L:A ratio is strongly correlated with anthropometric measurements suggesting central obesity. Conclusions Infants in the experimental arm have central obesity and higher serum L:A ratio compared with controls. Notably, serum L:A ratio is strongly correlated with weight gain. Trial registration This randomized controlled trial was registered at ClinicalTrials.gov NCT02372136.


  • Factors Associated with Need for Intravenous Glucose Infusion for the Treatment of Early Neonatal Hypoglycemia in Late Preterm and Term Neonates

    by Luc P. Brion, Lisa M. Scheid, L Steven Brown, Patti J. Burchfield, Charles R. Rosenfeld

    Objective The aim of this study was to determine which late-preterm (35–36 weeks' gestational age [GA]) and term neonates with early-onset hypoglycemia in the first 72 hours postnatal required a continuous glucose infusion to achieve and successfully maintain euglycemia. Study Design This is a retrospective cohort study of late preterm and term neonates born in 2010–2014 and admitted to the Mother-Baby Unit at Parkland Hospital who had laboratory-proven blood glucose concentration < 40 mg/dL (2.2 mmol/L) during the first 72 hours of life. Among the subgroup needing intravenous (IV) glucose infusion, we analyzed which factors predicted a maximum glucose infusion rate (GIR) ≥ 10 mg/kg/min. The entire cohort was randomly divided into a derivation cohort (n = 1,288) and a validation cohort (n = 1,298). Results In multivariate analysis, the need for IV glucose infusion was associated with small size for GA, low initial glucose concentration, early-onset infection, and other perinatal variables in both cohorts. A GIR ≥ 10 mg/kg/min was required in 14% of neonates with blood glucose value < 20 mg/dL during the first 3 hours of observation. The likelihood of a GIR ≥ 10 mg/kg/min was associated with lower initial blood glucose value and lower umbilical arterial pH. Conclusion Need for IV glucose infusion was associated with small size for GA, low initial glucose concentration, early-onset infection, and variables associated with perinatal hypoxia–asphyxia. The likelihood of a maximum GIR ≥ 10 mg/kg/min was greater in neonates with lower blood glucose value during the first 3 hours of observation and lower umbilical arterial pH. Key Points

  • Double-blinded randomized controlled trial of optimizing nutrition in preterm very low birth weight infants: Bayley scores at 18–38 months of age

    by Jordan D. Reis, Kristine Tolentino-Plata, Maria Caraig, Roy Heyne, Charles R. Rosenfeld, L. Steven Brown, Luc P. Brion

    Background Human milk supplementation for preterm infants in the neonatal intensive care unit (NICU) can be based on optimized nutrition (feeding adjustments based on growth and measurements of serum nutrients) or individualized nutrition (measurements of macronutrients in mother’s own milk). Objective To compare Bayley Scales of Infant and Toddler Development, Third Edition (BSID-III) at 18–38mo adjusted age in infants who had been randomly allocated to individualized+optimized nutrition (experimental group) vs optimized nutrition alone (control) in the NICU. Methods Double-blinded randomized controlled trial in neonates NCT02372136.


  • Open Access

    Factors Associated with Need for Intravenous Glucose Infusion for the Treatment of Early Neonatal Hypoglycemia in Late Preterm and Term infants

    by Luc Brion, Lisa Scheid, Larry Brown, Patti Burchfield, Charles Rosenfeld

    Objective To determine which late-preterm (35-36wk gestational age [GA]) and term neonates with early-onset hypoglycemia in the first 72h postnatal required a continuous glucose infusion in order to achieve and successfully maintain euglycemia. Study Design: Retrospective cohort study of late preterm and term neonates born in 2010–2014 and admitted to the Mother-Baby Unit at Parkland Hospital who had laboratory-proven blood glucose concentration < 40 mg/dL (2.2 mmol/L) during the first 72h of life. The cohort was randomly divided into a derivation cohort (n = 1288) and a validation cohort (n = 1298). Result In multivariate analysis, need for intravenous glucose infusion was associated with small size for GA, low initial glucose concentration, early-onset infection and other perinatal variables (e.g., fetal acidosis, hypoxic-ischemic encephalopathy) in both cohorts. Conclusion Need for intravenous glucose infusion was associated with small size for GA, low initial glucose concentration, early-onset infection and variables associated with prenatal hypoxia-asphyxia.

  • Persistent high blood pressure and renal dysfunction in preterm infants during childhood

    by Jessica Wickland, L. Steven Brown, Valerie Blanco, Roy Heyne, Christy Turer, Charles R. Rosenfeld

    Background Infants born very preterm (≤32 weeks gestational age, GA) and very-low birth weight (≤1500 g; PT-VLBW) demonstrate high systolic blood pressure (SBP), renal dysfunction, and obesity at 6 months–3 years and in early adulthood. Their parallel measurement and progression during childhood is unclear. Methods We reenrolled 62/120 patients originally seen at 1–3 years at 10–13 years and remeasured anthropometric indices, SBP, and serum creatinine (Cr) and cystatin C (cysC) to determine estimated glomerular filtration rate (eGFR). We selected Term-matched Controls at 10–13 years from the 2015–2016 NHANES database at a ratio of 2 Controls:1 Case (124:62). Results Reenrolled patients were predominantly Hispanic, birth weight 1073 ± 251 g, and GA at birth 28 ± 2 weeks. At 10–13 years, 45% were classified overweight/obese, 48% had SBP ≥ 90th centile (77% considered hypertensive), and 34% had low eGFR (−1 [1.73 m2]−1). Notably, 57% of reenrolled PT-VLBW Cases had low eGFRcysC at both 1–3 and 10–13 years, P < 0.03. Compared to Controls, Cases had four times the adjusted odds for having an elevated SBP and low eGFRCr despite similar proportions with overweight/obesity among Cases and Controls. Conclusions PT-VLBW infants seen at 1–3 years exhibit obesity, elevated SBP, and low eGFR in infancy and 10–13 years. Although the small sample size may limit conclusions, pediatricians should consider serial evaluations of PT-VLBW throughout childhood. Impact The association between preterm birth and elevated blood pressure, renal dysfunction, and obesity in young adults begins as early as 1 year and persists at 10–13 years of age. This is the first study reporting serial measurements of blood pressure, renal function, and obesity from infancy to preadolescence in children born very preterm. Fifty-seven percent of preterm 1–3 year olds have persistent low estimated glomerular filtration rate associated with hypertension at 10–13 years. Clinicians should consider serial evaluations of blood pressure, renal function, and obesity throughout infancy and childhood in all preterm births.


  • Association of antenatal steroids with surfactant administration in moderate preterm infants born to women with diabetes mellitus and/or hypertension

    by Heather M. Weydig, Charles R. Rosenfeld, Myra H. Wyckoff, Mambarambath A. Jaleel, Patti J. Burchfield, Anita Thomas, Mackenzie S. Frost, Luc P. Brion

    Background Randomized trials of antenatal steroid administration (ANS) for extreme or moderate preterm pregnancies excluded women with diabetes mellitus (DM) and included few with preeclampsia. Methods Cohort study (n = 1,813) including moderate preterm births [290/7–336/7wks’ gestational age GA)] before (Epoch-1) and after (Epoch-2) expansion of ANS administration to women with hypertensive disorders (HTN) and/or DM. We compared surfactant administration in Group-1 (neither HTN nor DM), Group-2a (HTN not DM), Group-2b (DM not HTN) and Group-2c (DM and HTN). Results Surfactant administration was less frequent after ANS in Group-1 [adjusted odds ratio (aOR) 0.54, 95% confidence interval (CI) 0.31, 0.93, P = 0.03], Group-2a (aOR 0.36, CI 0.22, 0.58, P < 0.001) and Group-2c (aOR 0.29, CI 0.12, 0.71, P = 0.007) but not Group-2b (P = 0.64). Conclusions ANS administration was independently associated with less surfactant administration in moderately preterm neonates whose mothers had neither HTN nor DM, and those with HTN, but not those with DM without HTN.


  • Association of antenatal steroids with neonatal mortality and morbidity in preterm infants born to mothers with diabetes mellitus and hypertension

    by Heather M. Weydig, Charles R. Rosenfeld, Mambarambath A. Jaleel, Patti J. Burchfield, Mackenzie S. Frost, Luc P. Brion

    Background Randomized trials of antenatal steroids (ANS) included women at 24–33 weeks gestational age (GA); however, few women had preeclampsia and women with diabetes mellitus (DM) were excluded. Methods Cohort study including preterm births at 230/7–286/7 weeks GA before (Epoch-1) and after (Epoch-2) expansion of ANS administration to women with DM and hypertensive disorders (HTN). We compared Group-A (neither DM nor HTN) and Group-B (DM and/or HTN). Results Among 747 neonates the adjusted odds ratio (aOR) for surfactant administration, in-hospital mortality, severe intraventricular hemorrhage (IVH) and death or severe IVH were lower in ANS-exposed neonates than unexposed neonates. In Group-B, ANS administration was independently associated with less severe IVH and less death or severe IVH, but not less surfactant use or mortality. Conclusions Increased ANS administration in women with DM and/or HTN was independently associated with less severe IVH and less death or severe IVH but without decrease in surfactant administration.


  • Quality improvement project designed to reduce disproportionate growth in extremely low gestational age neonates: cognitive neurodevelopmental outcome at 18–41 months

    by Jordan D. Reis, Kristine Tolentino-Plata, Roy Heyne, L. Steven Brown, Charles R. Rosenfeld, Maria Caraig, Patti J. Burchfield, Luc P. Brion

    Objective To assess if the adjusted odds of low composite cognitive Bayley-III scores changed after implementing a single-institution quality improvement (QI) project designed to decrease discharge Z-scores for weight, body mass index (BMI), and weight-for-length, but not length or fronto-occipital circumference (FOC) in infants 23–28 weeks gestational age (GA). Methods Compare Bayley-III outcomes at ≥18 months corrected age (postnatal age adjusted for prematurity) in infants tested before (Epoch-1) and after (Epoch-2) QI implementation. Results Bayley testing was available in 134/156 infants (86%) in Epoch-1 and 139/175 (79%) in Epoch-2. There was no change in frequency of low (p = 0.5) or in median cognitive scores (80 in Epoch-1 vs. 85 Epoch-2, p = 0.35). The adjusted odds of low cognitive scores was not different between Epochs. Conclusion No change in cognitive outcome at ≥18 months corrected age was observed after implementing a QI project designed to reduce discharge weight-for-length disproportion in very preterm infants.


  • Association of age of initiation and type of complementary foods with body mass index and weight-for-length at 12 months of age in preterm infants

    by Luc P. Brion, Charles R. Rosenfeld, Roy Heyne, L. Steven Brown, Cheryl S. Lair, Elizabeth Heyne, Emily L. Dohoney, Patti J. Burchfield, Maria Caraig

    Objective To assess whether in very preterm infants (1) body mass index (BMI) Z-score and weight-for-length (WtFL) Z-score at 1 year of age and (2) head growth from discharge to 1 year are associated with breastfeeding at discharge and the age of onset and type of complementary foods. Study design Observational cohort study. Results Infants started on only ready-made complementary (RMC) feedings at ≤26 weeks adjusted age had the highest adjusted BMI Z-score and WtFL Z-score at 1 year of age. Adjusted change in fronto-occipital circumference was highest in infants either discharged on breastmilk or receiving home-made complementary food with/without RMC (HMM) at ≤26 weeks adjusted age. Conclusions Infants started on RMC ≤26 weeks adjusted age had the highest BMI Z-score and WtFL Z-score at 1 year. Head growth from discharge to 1 year was highest in infants either discharged on breastmilk or receiving HMM at ≤26 weeks adjusted age.